NCT01905631View on ClinicalTrials.gov

Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
PruritusAtopic Dermatitis
Interventions
DRUG

Aurstat Anti-Itch Hydrogel (Aurstat)

Subjects will apply Aurstat Anti-Itch Hydrogel 2 times daily or as needed for up to three days to reduce itching. Subjects will also fill out a study diary assessing adverse events or other events they experience during the trial.

Trial Locations (1)

33180

Center for Clinical and Cosmetic Research, Aventura

Sponsors

Collaborators (1)

Onset Dermatologics, Inc.
All Listed Sponsors
collaborator

Onset Dermatologics, Inc.

UNKNOWN

lead

The Center for Clinical and Cosmetic Research

OTHER